Skip to content

Zhongwei Xiong

4 papers in the library · 175 citations · publishing 2018-2024

Papers

Sort Most recent Most cited

Effects of an online mindfulness-based cognitive therapy for caregivers of children with allergic rhinitis.

Frontiers in Psychology 2024 Xixi Yan, Zhongwei Xiong, Huimin Sun et al. 1 citation

The incidence of allergic rhinitis in children is high across the world, as well as in China. Allergic rhinitis in children has serious impact on physical and mental health of the children. At the same time, the caregivers of allergic rhinitis children have heavy burden of care, and their mental problems are severe. It is necessary to implement timely psychological intervention for the...

Beneficial effects of (R)-ketamine, but not its metabolite (2R,6R)-hydroxynorketamine, in the depression-like phenotype, inflammatory bone markers, and bone mineral density in a chronic social defeat stress model.

Behavioural Brain Research August 1, 2019 Zhongwei Xiong, Yuko Fujita, Kai Zhang et al.

Inflammatory bone markers may play a role in the antidepressant actions of (R)-ketamine in susceptible mice after chronic social defeat stress (CSDS). In this study, we compared the effects of (R)-ketamine and its final metabolite (2R,6R)-hydroxynorketamine (HNK) in depression-like phenotypes, inflammatory bone markers and bone mineral density (BMD) in CSDS susceptible mice. We measured plasma...

Comparison of antidepressant and side effects in mice after intranasal administration of (R,S)-ketamine, (R)-ketamine, and (S)-ketamine.

Pharmacology, Biochemistry, and Behavior June 1, 2019 Lijia Chang, Kai Zhang, Yaoyu Pu et al. 174 citations

The N-methyl-d-aspartate receptor (NMDAR) antagonist (R,S)-ketamine produces rapid and sustained antidepressant effects in treatment-resistant patients with depression although intranasal use of (R,S)-ketamine in ketamine abusers is popular. In March 5, 2019, nasal spray of (S)-ketamine for treatment-resistant depression was approved as a new antidepressant by the US Food Drug Administration....

Comparison of rapid and long-lasting antidepressant effects of negative modulators of α5-containing GABAA receptors and (R)‑ketamine in a chronic social defeat stress model.

Pharmacology, Biochemistry, and Behavior December 2018 Zhongwei Xiong, Kai Zhang, Tamaki Ishima et al.

The negative allosteric modulators (NAMs: L-655,708 and MRK-016) of α5 subunit-containing GABAA receptors are reported to show rapid-acting antidepressant effects in rodents. However, there are no reports comparing these NAMs and (R)‑ketamine, (R)-enantiomer of the rapid-acting antidepressant ketamine, in a chronic social defeat stress (CSDS) model. Here we measured expression of α5 GABAA...

DOI: 10.1016/j.pbb.2018.10.005 (opens in new tab) Full text (opens in new tab) R‑ketamine Antidepressant Negative allosteric modulators Postmortem brain +1